TSPO and neoplasm: For example, progress has been made to detect and monitor CD11b, a tumor-associated myeloid marker, CD206, which is highly expressed in M2 macrophages, and TSPO, a mitochondrial receptor upregulated in activated macrophages via novel PET imaging agents (83–86).